C Nannini

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
    Carlotta Nannini
    Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Res Ther 10:R124. 2008
  2. ncbi Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study
    C Nannini
    Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Lupus 18:394-9. 2009

Detail Information

Publications2

  1. ncbi Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
    Carlotta Nannini
    Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Res Ther 10:R124. 2008
    ..The purpose of the present study was to systematically review the effect of cyclophosphamide treatment on pulmonary function in patients with systemic sclerosis and interstitial lung disease...
  2. ncbi Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study
    C Nannini
    Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Lupus 18:394-9. 2009
    ..MMF treatment significantly reduced the total number of lupus flares and prednisone requirements. Even with the reduction in mean daily prednisone dose, both the SLEDAI and physican global assessment also improved during MMF therapy...